{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:05:42Z","timestamp":1778724342068,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.08.019","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T19:19:07Z","timestamp":1313522347000},"page":"7618-7623","source":"Crossref","is-referenced-by-count":25,"title":["Physico-chemical properties of Salmonella typhi Vi polysaccharide\u2013diphtheria toxoid conjugate vaccines affect immunogenicity"],"prefix":"10.1016","volume":"29","author":[{"given":"So Jung","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Kyung","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeep","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deok Ryun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg W.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney","family":"Carbis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.08.019_bib0005","unstructured":"WHO Weekly epidemiological record no. 6; 2008, 49\u201360."},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.019_bib0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1586\/erv.10.43","article-title":"Population impact of Vi capsular polysaccharide vaccine","volume":"9","author":"Khan","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.08.019_bib0015","series-title":"Vaccines for biodefense and emerging and neglected diseases","first-page":"1147","article-title":"Typhoid fever","author":"Kingsley","year":"2009"},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.019_bib0020","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"21","key":"10.1016\/j.vaccine.2011.08.019_bib0025","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.vaccine.2004.11.044","article-title":"Policymakers\u2019 views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia","volume":"23","author":"DeRoeck","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.08.019_bib0030","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/infdis\/150.3.436","article-title":"Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi","volume":"150","author":"Robbins","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.019_bib0035","first-page":"169","article-title":"Prevention of invasive bacterial diseases by immunization with polysaccharide\u2013protein conjugates","volume":"146","author":"Robbins","year":"1989","journal-title":"Curr Top Microbiol Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.08.019_bib0040","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/infdis\/165-Supplement_1-S49","article-title":"Thymus-independent and thymus-dependent responses to polysaccharide antigens","volume":"165","author":"Stein","year":"1992","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.019_bib0045","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1084\/jem.166.5.1510","article-title":"Vi capsular polysaccharide\u2013protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals","volume":"166","author":"Szu","year":"1987","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2011.08.019_bib0050","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.65.6.2088-2093.1997","article-title":"Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker","volume":"65","author":"Kossaczka","year":"1997","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.019_bib0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jbiotec.2008.02.017","article-title":"Optimization of Vi capsular polysaccharide production during growth of Salmonella enterica serotype Typhi Ty2 in a bioreactor","volume":"135","author":"Jang","year":"2008","journal-title":"J Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.019_bib0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.provac.2010.03.014","article-title":"Development of an efficient and scalable method for processing and purification of Vi capsular polysaccharide","volume":"2","author":"Kothari","year":"2010","journal-title":"Proc Vaccinol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.019_bib0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Randall RJ protein measurement with Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2011.08.019_bib0070","series-title":"WHO technical reports series, no. 840, 1994. Requirements for Vi polysaccharide typhoid vaccine","author":"WHO","year":"1994"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.019_bib0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide\u2013protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.019_bib0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9258(18)56740-5","article-title":"The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application","volume":"180","author":"Hestrin","year":"1949","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.019_bib0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/CVI.00266-09","article-title":"Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide\u2013diphtheria toxoid conjugates","volume":"17","author":"Cui","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.08.019_bib0090","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2010.11.022","article-title":"Vi-CRM197 as a new conjugate vaccine against Salmonella typhi","volume":"29","author":"Micoli","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.019_bib0095","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/CVI.00387-10","article-title":"Evaluation of the immunogenicity and biological activity of Citrobacter freundii Vi CRM197 conjugates as a vaccine for S. typhi","volume":"18","author":"Rondini","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.08.019_bib0100","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1128\/IAI.62.10.4440-4444.1994","article-title":"Laboratory and preliminary clinical characterization of Vi capsular polysaccharide\u2013protein conjugate vaccines","volume":"62","author":"Szu","year":"1994","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2011.08.019_bib0105","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"67","author":"Kossaczka","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.019_bib0110","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"Vi conjugate typhoid vaccine (Vi-rEPA) is safe, elicits protective levels of IgG anti-Vi and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.08.019_bib0145","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0008-6215(00)82210-7","article-title":"Strukturaufklarung des Vi-Antigens aus Citrobacter freundii (E. coli) 5396\/38","volume":"3","author":"Heyns","year":"1967","journal-title":"Carbohydr Res"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.08.019_bib0120","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0264-410X(99)00232-7","article-title":"Glycoprotein conjugate vaccines","volume":"17","author":"Lindberg","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.019_bib0125","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1128\/IAI.66.5.2186-2192.1998","article-title":"Structural properties of Group B Streptococcal Type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy","volume":"66","author":"Wessels","year":"1998","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2011.08.019_bib0130","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/IAI.57.12.3823-3827.1989","article-title":"Comparative immunogenicities of Vi polysaccharide\u2013protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi","volume":"57","author":"Szu","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.019_bib0135","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1542\/peds.92.3.480","article-title":"Committee on infectious diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines","volume":"92","author":"American Academy of Pediatrics","year":"1993","journal-title":"Pediatrics"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.08.019_bib0140","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/0264-410X(93)90160-Y","article-title":"Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines","volume":"11","author":"Granoff","year":"1993","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101228X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101228X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T06:03:23Z","timestamp":1712729003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1101228X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":28,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X1101228X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}